CG
XLRN
Cutler Group’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-71,931
| Closed | -$12.4M | – | 2927 |
|
|
2021
Q3 | $12.4M | Buy |
71,931
+70,893
| +6,830% | +$12.2M | 0.56% | 16 |
|
|
2021
Q2 | $130K | Buy |
+1,038
| New | +$130K | 0.01% | 886 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2901 |
|
|
2020
Q3 | – | Sell |
-6,887
| Closed | -$656K | – | 2469 |
|
|
2020
Q2 | $656K | Buy |
6,887
+5,987
| +665% | +$570K | 0.04% | 226 |
|
|
2020
Q1 | $80K | Sell |
900
-2,500
| -74% | -$222K | ﹤0.01% | 668 |
|
|
2019
Q4 | $180K | Sell |
3,400
-4,000
| -54% | -$212K | 0.01% | 540 |
|
|
2019
Q3 | $292K | Sell |
7,400
-1,500
| -17% | -$59.2K | 0.03% | 337 |
|
|
2019
Q2 | $365K | Buy |
8,900
+4,299
| +93% | +$176K | 0.03% | 313 |
|
|
2019
Q1 | $214K | Sell |
4,601
-300
| -6% | -$14K | 0.02% | 425 |
|
|
2018
Q4 | $213K | Buy |
+4,901
| New | +$213K | 0.02% | 383 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2377 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 2469 |
|
|
2018
Q1 | – | Sell |
-39
| Closed | -$1K | – | 2710 |
|
|
2017
Q4 | $1K | Sell |
39
-1,671
| -98% | -$42.8K | ﹤0.01% | 2020 |
|
|
2017
Q3 | $63K | Buy |
+1,710
| New | +$63K | ﹤0.01% | 1178 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 3520 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3569 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3585 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3558 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3555 |
|
|
2016
Q1 | – | Sell |
-238
| Closed | -$11K | – | 3570 |
|
|
2015
Q4 | $11K | Buy |
+238
| New | +$11K | ﹤0.01% | 2151 |
|